Acta Scientific Pharmaceutical Sciences (ASPS)(ISSN: 2581-5423)

Review Article Volume 5 Issue 9

Drug Delivery Via Lyotropic Liquid Crystals: An Innovative Approach

Anureet Kaur1, Lakhvir Kaur1*, Gurjeet Singh1, RK Dhawan2 and Ayushi Mahajan1

1Department of Pharmaceutics, Khalsa College of Pharmacy, Amritsar, India
2Department of Pharmacology, Khalsa College of Pharmacy, Amritsar, India

*Corresponding Author: Lakhvir Kaur, Department of Pharmaceutics, Khalsa College of Pharmacy, Amritsar, India.

Received: July 16, 2021; Published: August 31, 2021


  The lyotropic liquid crystal are self-assembled mesophases that exhibit the properties of both crystalline solid and isotropic liquids. They can potentially deliver hydrophilic, lipophilic, amphiphilic molecules including proteins and peptides. The unique structure of liquid crystals facilitates the improved drug loading and controlled release of the drug. Liquid crystals are widely explored for topical delivery of drugs because of their strong bio-adhesive property and resemblance to the structure of the biological membrane when applied topically. The biological membrane like structure of LLC improves the skin retention and permeation of the drugs. Lyotropic liquid crystals are mainly classified into three main categories i.e., lamellar, hexagonal and cubic. The structural difference between various types of liquid crystals can be determined by using a number of characterization techniques such as transmission electron microscopy, small angle x-ray diffraction and polarized light microscopy. In this review, we have discussed the classification, preparation and characterization of liquid crystals along with their various therapeutic applications. We have discussed the potential effect of liquid crystals in brain targeting via intranasal route and its applications in targeting various types of tumour cells.

Keywords: Lyotropic Liquid Crystals; Cubosomes; Hexosomes; Transdermal Delivery; Brain Targeting; Tumour Targeting


  1. Madheswaran T., et al. “Current Potential and Challenges in the Advances of Liquid Crystalline Nanoparticles as Drug Delivery Systems”. Drug Discovery Today7 (2019): 1405-1412.
  2. Rapalli VK., et al. “Insights of Lyotropic Liquid Crystals in Topical Drug Delivery for Targeting Various Skin Disorders”. Journal of Molecular Liquids 315 (2020): 113771.
  3. Loo YS., et al. “Encapsulation of Berberine into Liquid Crystalline Nanoparticles to Enhance Its Solubility and Anticancer Activity in MCF7 Human Breast Cancer Cells”. Journal of Drug Delivery Science and Technology 57 (2020): 101756.
  4. Sagalowicz L., et al. “Monoglyceride Self-Assembly Structures as Delivery Vehicles”. Trends in Food Science and Technology5 (2006): 204-214.
  5. Guo C., et al. “Lyotropic Liquid Crystal Systems in Drug Delivery”. Drug Discovery Today23-24 (2010): 1032-1040.
  6. Grumezescu AM., et al. “Organic Materials as Smart Nanocarriers for Drug Delivery”. William Andrew Publishing (2018): 471-517.
  7. Boyd BJ., et al. “Nonlamellar Liquid Crystalline Nanostructured Particles: Advances in Materials and Structure Determination”. Journal of Liposome Research1 (2009): 12-28.
  8. Esposito E., et al. “Lipid-Based Supramolecular Systems for Topical Application: A Preformulatory Study”. AAPS PharmSci4 (2003): 62-76.
  9. Spicer PT., et al. “Novel Process for Producing Cubic Liquid Crystalline Nanoparticles (Cubosomes)”. Langmuir19 (2001): 5748-5756.
  10. Chlanda P., and Martin Sachse. “Cryo-Electron Microscopy of Vitreous Sections”. Methods in Molecular Biology (2013): 193-214.
  11. Dobro MJ., et al. “Plunge Freezing for Electron Cryomicroscopy”. Methods in Enzymology (2010): 63-82.
  12. Kim DH., et al. “A Simple Evaporation Method for Large-Scale Production of Liquid Crystalline Lipid Nanoparticles with Various Internal Structures”. ACS Applied Materials and Interfaces36 (2015): 20438-20446.
  13. Zeng N., et al. “Preparation and Characterization of Paclitaxel-Loaded DSPE-PEG-Liquid Crystalline Nanoparticles (LCNPs) for Improved Bioavailability”. International Journal of Pharmaceutics1-2 (2012): 58-66.
  14. Alfagih IM., et al. “Cubosomes Dispersions as Enhanced Indomethacin Oral Delivery Systems: In Vitro and Stability Evaluation”. Journal of Pharmaceutical Research International (2021): 24-35.
  15. Freag MS., et al. “Layer-by-Layer-Coated Lyotropic Liquid Crystalline Nanoparticles for Active Tumor Targeting of Rapamycin”. Nanomedicine22 (2016): 2975-2996.
  16. Nasr M., et al. “Formulation and Evaluation of Cubosomes Containing Colchicine for Transdermal Delivery”. Drug Delivery and Translational Research5 (2020): 1302-1313.
  17. Mahmood A., et al. “Luliconazole Loaded Lyotropic Liquid Crystalline Nanoparticles for Topical Delivery: QbD Driven Optimization, in-Vitro Characterization and Dermatokinetic Assessment”. Chemistry and Physics of Lipids 234 (2021): 105028.
  18. Kurangi B., et al. “Formulation and Evaluation of Resveratrol Loaded Cubosomal Nanoformulation for Topical Delivery”. Current Drug Delivery 17 (2020).
  19. Janakiraman K., et al. “Development of Methotrexate-Loaded Cubosomes with Improved Skin Permeation for the Topical Treatment of Rheumatoid Arthritis”. Applied Nanoscience8 (2019): 1781-1796.
  20. Bakr MM., et al. “In Situ Hexosomal Gel as a Promising Tool to Ameliorate the Transnasal Brain Delivery of Vinpocetine: Central Composite Optimization and In Vivo Biodistribution”. Journal of Pharmaceutical Sciences 7 (2020): 2213-2223.
  21. See GL., et al. “Enhanced Nose-to-Brain Delivery of Tranilast Using Liquid Crystal Formulations”. Journal of Controlled Release 325 (2020): 1-9.
  22. David SR., et al. “Development and Evaluation of Curcumin Liquid Crystal Systems for Cervical Cancer”. Scientia Pharmaceutica1 (2020): 15.
  23. Thapa RK., et al. “Multilayer-Coated Liquid Crystalline Nanoparticles for Effective Sorafenib Delivery to Hepatocellular Carcinoma”. ACS Applied Materials and Interfaces36 (2015): 20360-20368.
  24. Rapalli VK., et al. “QbD-Driven Formulation Development and Evaluation of Topical Hydrogel Containing Ketoconazole Loaded Cubosomes”. Materials Science and Engineering: C 119 (2021): 111548.
  25. Oyafuso M., et al. “Development and In Vitro Evaluation of Lyotropic Liquid Crystals for the Controlled Release of Dexamethasone”. Polymers12 (2017): 330.
  26. Al-mahallawi AM., et al. “Norfloxacin Loaded Nano-Cubosomes for Enhanced Management of Otitis Externa: In Vitro and in Vivo Evaluation”. International Journal of Pharmaceutics 600 (2021): 120490.
  27. De-Souza IF., et al. “The Liquid Crystalline Phase Behaviour of a Nasal Formulation Modifies the Brain Disposition of Donepezil in Rats in the Treatment of Alzheimer’s Disease”. Colloids and Surfaces B: Biointerfaces 203 (2021): 111721.


Citation: Lakhvir Kaur., et al. “Drug Delivery Via Lyotropic Liquid Crystals: An Innovative Approach". Acta Scientific Pharmaceutical Sciences 5.9 (2020): 94-101.


Copyright: © 2020 Lakhvir Kaur., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Acceptance rate32%
Acceptance to publication20-30 days

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is July 30, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US